Bausch & Lomb Stock Rides An 8-Day Winning Streak To A 24% Gain
Bausch & Lomb (BLCO) stock is on an 8-day winning streak, up 23.7% since the run began. That added about $1.4 billion to the company’s market value, which now stands at about $7.3 billion. The stock closed at $20.40 on Wednesday, October 28, its highest close of the past year.
The Streak Next To The S&P 500
Returns for BLCO and the S&P 500 over the streak and the periods around it, all ending Wednesday, October 28 and including dividends:
| Return Period | BLCO | S&P 500 |
|---|---|---|
| 1 Day | 15.8% | 0.3% |
| 8 Days (Current Streak) | 23.7% | 1.1% |
| 1 Month (21 Trading Days) | 19.0% | 1.0% |
| 3 Months (63 Trading Days) | 20.1% | 4.4% |
| Year To Date | 19.4% | 14.2% |
| 1 Year (252 Trading Days) | 32.7% | 14.0% |
Is This Move About Bausch & Lomb Or The Market?
Over the same 8 trading days, the S&P 500 returned +1.1% including dividends, so the run is mostly Bausch & Lomb’s own story rather than the market’s. Over the past three months the stock is up 20.1%, a window that includes the streak; over the other 55 sessions of that window it was down 2.9%.
Do The Fundamentals Support The Run?
On the fundamentals, revenue grew 8.9% over the last twelve months, against a median of 7.9% for S&P 500 Health Care stocks; and its operating margin is 7.6%, versus a median of 17.6%. Bausch & Lomb does not have positive trailing earnings, so there is no meaningful price-to-earnings multiple to compare. The read is mixed: revenue growth above the median on one side, margins below the median on the other.
If you are looking for strength with more behind it than a hot tape, our Guidance Momentum screen surfaces the names where management raised its own outlook.
Prefer the theme to the single name? A health care ETF like XLV holds the whole group, not just this stock. It is still a concentrated bet on one theme, which is the gap the portfolio below is built to close.
Streaks End. Discipline Compounds
A run like this is genuinely useful information: something about this business has the market’s full attention. But streaks are where discipline gets tested, because the urge to chase strength is strongest right before it pauses.
The Trefis High Quality (HQ) Portfolio channels that urge into a system: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules rather than excitement. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Enjoy the streak; own the process.